Skip to main content
Top
Published in: Respiratory Research 1/2013

Open Access 01-12-2013 | Research

GST-omega genes interact with environmental tobacco smoke on adult level of lung function

Authors: Kim de Jong, H Marike Boezen, Nick HT ten Hacken, Dirkje S Postma, Judith M Vonk, the LifeLines cohort study

Published in: Respiratory Research | Issue 1/2013

Login to get access

Abstract

Background

Lung growth in utero and lung function loss during adulthood can be affected by exposure to environmental tobacco smoke (ETS). The underlying mechanisms have not been fully elucidated. Both ETS exposure and single nucleotide polymorphisms (SNPs) in Glutathione S-Transferase (GST) Omega genes have been associated with the level of lung function. This study aimed to assess if GSTO SNPs interact with ETS exposure in utero and during adulthood on the level of lung function during adulthood.

Methods

We used cross-sectional data of 8,128 genotyped participants from the LifeLines cohort study. Linear regression models (adjusted for age, sex, height, weight, current smoking, ex-smoking and packyears smoked) were used to analyze the associations between in utero, daily and workplace ETS exposure, GSTO SNPs, the interaction between ETS and GSTOs, and level of lung function (FEV1, FEV1/FVC). Since the interactions between ETS and GSTOs may be modified by active tobacco smoking we additionally assessed associations in never and ever smokers separately. A second sample of 5,308 genotyped LifeLines participants was used to verify our initial findings.

Results

Daily and workplace ETS exposure was associated with significantly lower FEV1 levels. GSTO SNPs (recessive model) interacted with in utero ETS and were associated with higher levels of FEV1, whereas the interactions with daily and workplace ETS exposure were associated with lower levels of FEV1, effects being more pronounced in never smokers. The interaction of GSTO2 SNP rs156697 with in utero ETS associated with a higher level of FEV1 was significantly replicated in the second sample. Overall, the directions of the interactions of in utero and workplace ETS exposure with the SNPs found in the second (verification) sample were in line with the first sample.

Conclusions

GSTO genotypes interact with in utero and adulthood ETS exposure on adult lung function level, but in opposite directions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hospers JJ, Schouten JP, Weiss ST, Postma DS, Rijcken B: Eosinophilia is associated with increased all-cause mortality after a follow-up of 30 years in a general population sample. Epidemiology. 2000, 11: 261-268. 10.1097/00001648-200005000-00006.PubMedCrossRef Hospers JJ, Schouten JP, Weiss ST, Postma DS, Rijcken B: Eosinophilia is associated with increased all-cause mortality after a follow-up of 30 years in a general population sample. Epidemiology. 2000, 11: 261-268. 10.1097/00001648-200005000-00006.PubMedCrossRef
2.
go back to reference Knuiman MW, James AL, Divitini ML, Ryan G, Bartholomew HC, Musk AW: Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study. Ann Epidemiol. 1999, 9: 297-306.PubMedCrossRef Knuiman MW, James AL, Divitini ML, Ryan G, Bartholomew HC, Musk AW: Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study. Ann Epidemiol. 1999, 9: 297-306.PubMedCrossRef
3.
go back to reference Doruk S, Ozyurt H, Inonu H, Erkorkmaz U, Saylan O, Seyfikli Z: Oxidative status in the lungs associated with tobacco smoke exposure. Clin Chem Lab Med. 2011, 49: 2007-2012.PubMedCrossRef Doruk S, Ozyurt H, Inonu H, Erkorkmaz U, Saylan O, Seyfikli Z: Oxidative status in the lungs associated with tobacco smoke exposure. Clin Chem Lab Med. 2011, 49: 2007-2012.PubMedCrossRef
4.
go back to reference Lodrup Carlsen KC, Jaakkola JJ, Nafstad P, Carlsen KH: In utero exposure to cigarette smoking influences lung function at birth. Eur Respir J. 1997, 10: 1774-1779. 10.1183/09031936.97.10081774.PubMedCrossRef Lodrup Carlsen KC, Jaakkola JJ, Nafstad P, Carlsen KH: In utero exposure to cigarette smoking influences lung function at birth. Eur Respir J. 1997, 10: 1774-1779. 10.1183/09031936.97.10081774.PubMedCrossRef
5.
go back to reference Stick SM, Burton PR, Gurrin L, Sly PD, LeSouf PN: Effects of maternal smoking during pregnancy and a family history of asthma on respiratory function in newborn infants. Lancet. 1996, 348: 1060-1064. 10.1016/S0140-6736(96)04446-7.PubMedCrossRef Stick SM, Burton PR, Gurrin L, Sly PD, LeSouf PN: Effects of maternal smoking during pregnancy and a family history of asthma on respiratory function in newborn infants. Lancet. 1996, 348: 1060-1064. 10.1016/S0140-6736(96)04446-7.PubMedCrossRef
6.
go back to reference Eisner M: Environmental tobacco smoke exposure and pulmonary function among adults in NHANES III: impact on the general population and adults with current asthma. Environ Health Perspect. 2002, 110: 765-770. 10.1289/ehp.02110765.PubMedPubMedCentralCrossRef Eisner M: Environmental tobacco smoke exposure and pulmonary function among adults in NHANES III: impact on the general population and adults with current asthma. Environ Health Perspect. 2002, 110: 765-770. 10.1289/ehp.02110765.PubMedPubMedCentralCrossRef
7.
go back to reference Janson C, Chinn S, Jarvis D, Zock J, Torén K, Burney P: Effect of passive smoking on respiratory symptoms, bronchial responsiveness, lung function, and total serum IgE in the European Community Respiratory Health Survey: a cross-sectional study. Lancet. 2001, 358: 2103-2109. 10.1016/S0140-6736(01)07214-2.PubMedCrossRef Janson C, Chinn S, Jarvis D, Zock J, Torén K, Burney P: Effect of passive smoking on respiratory symptoms, bronchial responsiveness, lung function, and total serum IgE in the European Community Respiratory Health Survey: a cross-sectional study. Lancet. 2001, 358: 2103-2109. 10.1016/S0140-6736(01)07214-2.PubMedCrossRef
8.
go back to reference Leuenberger P, Schwartz J, Ackermann Liebrich U, Blaser K, Bolognini G, Bongard JP, Brandli O, Braun P, Bron C, Brutsche M: Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team. Am J Respir Crit Care Med. 1994, 150: 1222-1228. 10.1164/ajrccm.150.5.7952544.PubMedCrossRef Leuenberger P, Schwartz J, Ackermann Liebrich U, Blaser K, Bolognini G, Bongard JP, Brandli O, Braun P, Bron C, Brutsche M: Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team. Am J Respir Crit Care Med. 1994, 150: 1222-1228. 10.1164/ajrccm.150.5.7952544.PubMedCrossRef
9.
go back to reference Simoni M, Baldacci S, Puntoni R, Pistelli F, Farchi S, Lo Presti E, Pistelli R, Corbo G, Agabiti N, Basso S, Matteelli G, Di Pede F, Carrozzi L, Forastiere F, Viegi G: Respiratory symptoms/diseases and environmental tobacco smoke (ETS) in never smoker Italian women. Respir Med. 2007, 101: 531-538. 10.1016/j.rmed.2006.06.021.PubMedCrossRef Simoni M, Baldacci S, Puntoni R, Pistelli F, Farchi S, Lo Presti E, Pistelli R, Corbo G, Agabiti N, Basso S, Matteelli G, Di Pede F, Carrozzi L, Forastiere F, Viegi G: Respiratory symptoms/diseases and environmental tobacco smoke (ETS) in never smoker Italian women. Respir Med. 2007, 101: 531-538. 10.1016/j.rmed.2006.06.021.PubMedCrossRef
10.
go back to reference Eisner M, Balmes J, Katz P, Trupin L, Yelin E, Blanc P: Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health. 2005, 4: 7-7. 10.1186/1476-069X-4-7.PubMedPubMedCentralCrossRef Eisner M, Balmes J, Katz P, Trupin L, Yelin E, Blanc P: Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health. 2005, 4: 7-7. 10.1186/1476-069X-4-7.PubMedPubMedCentralCrossRef
11.
go back to reference Yin P, Jiang CQ, Cheng KK, Lam TH, Lam KH, Miller MR, Zhang WS, Thomas GN, Adab P: Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet. 2007, 370: 751-757. 10.1016/S0140-6736(07)61378-6.PubMedCrossRef Yin P, Jiang CQ, Cheng KK, Lam TH, Lam KH, Miller MR, Zhang WS, Thomas GN, Adab P: Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet. 2007, 370: 751-757. 10.1016/S0140-6736(07)61378-6.PubMedCrossRef
12.
go back to reference Wilk JB, Walter RE, Laramie JM, Gottlieb DJ, O'Connor GT: Framingham Heart Study genome-wide association: results for pulmonary function measures. BMC Med Genet. 2007, 8 (1): 8-CrossRef Wilk JB, Walter RE, Laramie JM, Gottlieb DJ, O'Connor GT: Framingham Heart Study genome-wide association: results for pulmonary function measures. BMC Med Genet. 2007, 8 (1): 8-CrossRef
13.
go back to reference Eaton DL, Bammler TK: Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci. 1999, 49: 156-164. 10.1093/toxsci/49.2.156.PubMedCrossRef Eaton DL, Bammler TK: Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci. 1999, 49: 156-164. 10.1093/toxsci/49.2.156.PubMedCrossRef
14.
go back to reference Hayes JD, Flanagan JU, Jowsey IR: Glutathione Transferases. Annu Rev Pharmacol Toxicol. 2005, 45: 51-88. 10.1146/annurev.pharmtox.45.120403.095857.PubMedCrossRef Hayes JD, Flanagan JU, Jowsey IR: Glutathione Transferases. Annu Rev Pharmacol Toxicol. 2005, 45: 51-88. 10.1146/annurev.pharmtox.45.120403.095857.PubMedCrossRef
15.
go back to reference Kabesch M, Hoefler C, Carr D, Leupold W, Weiland SK, von Mutius E: Glutathione S transferase deficiency and passive smoking increase childhood asthma. Thorax. 2004, 59: 569-573. 10.1136/thx.2003.016667.PubMedPubMedCentralCrossRef Kabesch M, Hoefler C, Carr D, Leupold W, Weiland SK, von Mutius E: Glutathione S transferase deficiency and passive smoking increase childhood asthma. Thorax. 2004, 59: 569-573. 10.1136/thx.2003.016667.PubMedPubMedCentralCrossRef
16.
go back to reference Schultz EN, Devadason SG, Khoo SK, Zhang G, Bizzintino JA, Martin AC, Goldblatt J, Laing IA, Le Souef PN, Hayden CM: The role of GSTP1 polymorphisms and tobacco smoke exposure in children with acute asthma. J Asthma. 2010, 47: 1049-1056.PubMed Schultz EN, Devadason SG, Khoo SK, Zhang G, Bizzintino JA, Martin AC, Goldblatt J, Laing IA, Le Souef PN, Hayden CM: The role of GSTP1 polymorphisms and tobacco smoke exposure in children with acute asthma. J Asthma. 2010, 47: 1049-1056.PubMed
17.
go back to reference Breton CV, Vora H, Salam MT, Islam T, Wenten M, Gauderman WJ, Van Den Berg D, Berhane K, Peters JM, Gilliland FD: Variation in the GST mu Locus and tobacco smoke exposure as determinants of childhood lung function. Am J Respir Crit Care Med. 2009, 179: 601-607. 10.1164/rccm.200809-1384OC.PubMedPubMedCentralCrossRef Breton CV, Vora H, Salam MT, Islam T, Wenten M, Gauderman WJ, Van Den Berg D, Berhane K, Peters JM, Gilliland FD: Variation in the GST mu Locus and tobacco smoke exposure as determinants of childhood lung function. Am J Respir Crit Care Med. 2009, 179: 601-607. 10.1164/rccm.200809-1384OC.PubMedPubMedCentralCrossRef
18.
go back to reference Board PG, Coggan M, Chelvanayagam G, Easteal S, Jermiin LS, Schulte GK, Danley DE, Hoth LR, Griffor MC, Kamath AV, Rosner MH, Chrunyk BA, Perregaux DE, Gabel CA, Geoghegan KF, Pandit J: Identification, characterization, and crystal structure of the omega class glutathione transferases. J Biol Chem. 2000, 275: 24798-24806. 10.1074/jbc.M001706200.PubMedCrossRef Board PG, Coggan M, Chelvanayagam G, Easteal S, Jermiin LS, Schulte GK, Danley DE, Hoth LR, Griffor MC, Kamath AV, Rosner MH, Chrunyk BA, Perregaux DE, Gabel CA, Geoghegan KF, Pandit J: Identification, characterization, and crystal structure of the omega class glutathione transferases. J Biol Chem. 2000, 275: 24798-24806. 10.1074/jbc.M001706200.PubMedCrossRef
19.
go back to reference Board PG: The omega-class glutathione transferases: structure, function, and genetics. Drug Metab Rev. 2011, 43: 226-235. 10.3109/03602532.2011.561353.PubMedCrossRef Board PG: The omega-class glutathione transferases: structure, function, and genetics. Drug Metab Rev. 2011, 43: 226-235. 10.3109/03602532.2011.561353.PubMedCrossRef
20.
go back to reference Whitbread AK, Tetlow N, Eyre HJ, Sutherland GR, Board PG: Characterization of the human Omega class glutathione transferase genes and associated polymorphisms. Pharmacogenetics. 2003, 13: 131-144. 10.1097/00008571-200303000-00003.PubMedCrossRef Whitbread AK, Tetlow N, Eyre HJ, Sutherland GR, Board PG: Characterization of the human Omega class glutathione transferase genes and associated polymorphisms. Pharmacogenetics. 2003, 13: 131-144. 10.1097/00008571-200303000-00003.PubMedCrossRef
21.
go back to reference Laliberte RE, Perregaux DG, Hoth LR, Rosner PJ, Jordan CK, Peese KM, Eggler JF, Dombroski MA, Geoghegan KF, Gabel CA: Glutathione S-Transferase Omega 1–1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1β posttranslational processing. J Biol Chem. 2003, 278: 16567-16578. 10.1074/jbc.M211596200.PubMedCrossRef Laliberte RE, Perregaux DG, Hoth LR, Rosner PJ, Jordan CK, Peese KM, Eggler JF, Dombroski MA, Geoghegan KF, Gabel CA: Glutathione S-Transferase Omega 1–1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1β posttranslational processing. J Biol Chem. 2003, 278: 16567-16578. 10.1074/jbc.M211596200.PubMedCrossRef
22.
go back to reference Pauwels NS, Bracke KR, Dupont LL, Van Pottelberge GR, Provoost S, Vanden Berghe T, Vandenabeele P, Lambrecht BN, Joos GF, Brusselle GG: Role of IL-1α and the Nlrp3/caspase-1/IL-1β axis in cigarette smoke-induced pulmonary inflammation and COPD. Eur Respir J. 2011, 38: 1019-1028. 10.1183/09031936.00158110.PubMedCrossRef Pauwels NS, Bracke KR, Dupont LL, Van Pottelberge GR, Provoost S, Vanden Berghe T, Vandenabeele P, Lambrecht BN, Joos GF, Brusselle GG: Role of IL-1α and the Nlrp3/caspase-1/IL-1β axis in cigarette smoke-induced pulmonary inflammation and COPD. Eur Respir J. 2011, 38: 1019-1028. 10.1183/09031936.00158110.PubMedCrossRef
23.
go back to reference Levy H, Murphy A, Zou F, Gerard C, Klanderman B, Schuemann B, Lazarus R, Garca KC, Celedn J, Drumm M, Dahmer M, Quasney M, Schneck K, Reske M, Knowles M, Pier G, Lange C, Weiss S: IL1B polymorphisms modulate cystic fibrosis lung disease. Pediatr Pulmonol. 2009, 44: 580-593. 10.1002/ppul.21026.PubMedPubMedCentralCrossRef Levy H, Murphy A, Zou F, Gerard C, Klanderman B, Schuemann B, Lazarus R, Garca KC, Celedn J, Drumm M, Dahmer M, Quasney M, Schneck K, Reske M, Knowles M, Pier G, Lange C, Weiss S: IL1B polymorphisms modulate cystic fibrosis lung disease. Pediatr Pulmonol. 2009, 44: 580-593. 10.1002/ppul.21026.PubMedPubMedCentralCrossRef
24.
go back to reference Harju TH, Peltoniemi MJ, Rytila PH, Soini Y, Salmenkivi KM, Board PG, Ruddock LW, Kinnula VL: Glutathione S-transferase omega in the lung and sputum supernatants of COPD patients. Respir Res. 2007, 8: 48-10.1186/1465-9921-8-48.PubMedPubMedCentralCrossRef Harju TH, Peltoniemi MJ, Rytila PH, Soini Y, Salmenkivi KM, Board PG, Ruddock LW, Kinnula VL: Glutathione S-transferase omega in the lung and sputum supernatants of COPD patients. Respir Res. 2007, 8: 48-10.1186/1465-9921-8-48.PubMedPubMedCentralCrossRef
25.
go back to reference Yanbaeva DG, Wouters EF, Dentener MA, Spruit MA, Reynaert NL: Association of glutathione-S-transferase omega haplotypes with susceptibility to chronic obstructive pulmonary disease. Free Radic Res. 2009, 43: 738-743. 10.1080/10715760903038440.PubMedCrossRef Yanbaeva DG, Wouters EF, Dentener MA, Spruit MA, Reynaert NL: Association of glutathione-S-transferase omega haplotypes with susceptibility to chronic obstructive pulmonary disease. Free Radic Res. 2009, 43: 738-743. 10.1080/10715760903038440.PubMedCrossRef
26.
go back to reference Stolk R, Rosmalen JGM, Postma D, de Boer R, Navis G, Slaets JPJ, Ormel J, Wolffenbuttel BHR: Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study. Eur J Epidemiol. 2008, 23: 67-74. 10.1007/s10654-007-9204-4.PubMedCrossRef Stolk R, Rosmalen JGM, Postma D, de Boer R, Navis G, Slaets JPJ, Ormel J, Wolffenbuttel BHR: Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study. Eur J Epidemiol. 2008, 23: 67-74. 10.1007/s10654-007-9204-4.PubMedCrossRef
27.
go back to reference Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B. 1995, 57: 289-300. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B. 1995, 57: 289-300.
28.
go back to reference Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993, 16: 5-40.PubMedCrossRef Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993, 16: 5-40.PubMedCrossRef
29.
go back to reference Gilliland FD, Berhane K, McConnell R, Gauderman WJ, Vora H, Rappaport EB, Avol E, Peters JM: Maternal smoking during pregnancy, environmental tobacco smoke exposure and childhood lung function. Thorax. 2000, 55: 271-276. 10.1136/thorax.55.4.271.PubMedPubMedCentralCrossRef Gilliland FD, Berhane K, McConnell R, Gauderman WJ, Vora H, Rappaport EB, Avol E, Peters JM: Maternal smoking during pregnancy, environmental tobacco smoke exposure and childhood lung function. Thorax. 2000, 55: 271-276. 10.1136/thorax.55.4.271.PubMedPubMedCentralCrossRef
30.
go back to reference Coiro V, Volpi R, Stella A, Cataldo S, Giumelli C, Maccanelli F, Araldi A, Chiodera P: Naloxone decreases the inhibitory effect of somatostatin on GH release induced by cigarette smoking in man. J Neural Transm. 2011, 118: 1173-1175. 10.1007/s00702-011-0610-0.PubMedCrossRef Coiro V, Volpi R, Stella A, Cataldo S, Giumelli C, Maccanelli F, Araldi A, Chiodera P: Naloxone decreases the inhibitory effect of somatostatin on GH release induced by cigarette smoking in man. J Neural Transm. 2011, 118: 1173-1175. 10.1007/s00702-011-0610-0.PubMedCrossRef
31.
go back to reference Beyea JA, Olson DM, Harvey S: Growth hormone (GH) action in the developing lung: changes in lung proteins after adenoviral GH overexpression. Dev Dyn. 2005, 234: 404-412. 10.1002/dvdy.20538.PubMedCrossRef Beyea JA, Olson DM, Harvey S: Growth hormone (GH) action in the developing lung: changes in lung proteins after adenoviral GH overexpression. Dev Dyn. 2005, 234: 404-412. 10.1002/dvdy.20538.PubMedCrossRef
32.
go back to reference Allen M, Zou F, Chai H, Younkin C, Miles R, Nair A, Crook J, Pankratz VS, Carrasquillo M, Rowley C, Nguyen T, Ma L, Malphrus K, Bisceglio G, Ortolaza A, Palusak R, Middha S, Maharjan S, Georgescu C, Schultz D, Rakhshan F, Kolbert C, Jen J, Sando S, Aasly J, Barcikowska M, Uitti R, Wszolek Z, Ross O, Petersen R, Graff Radford N, Dickson D, Younkin S, Ertekin-Taner N: Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications. Mol neurodegener. 2012, 7: 13-13. 10.1186/1750-1326-7-13.PubMedPubMedCentralCrossRef Allen M, Zou F, Chai H, Younkin C, Miles R, Nair A, Crook J, Pankratz VS, Carrasquillo M, Rowley C, Nguyen T, Ma L, Malphrus K, Bisceglio G, Ortolaza A, Palusak R, Middha S, Maharjan S, Georgescu C, Schultz D, Rakhshan F, Kolbert C, Jen J, Sando S, Aasly J, Barcikowska M, Uitti R, Wszolek Z, Ross O, Petersen R, Graff Radford N, Dickson D, Younkin S, Ertekin-Taner N: Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications. Mol neurodegener. 2012, 7: 13-13. 10.1186/1750-1326-7-13.PubMedPubMedCentralCrossRef
33.
go back to reference Olivieri M, Poli A, Zuccaro P, Ferrari M, Lampronti G, de Marco R, Lo Cascio V, Pacifici R: Tobacco smoke exposure and serum cotinine in a random sample of adults living in Verona, Italy. Arch Environ Health. 2002, 57: 355-359. 10.1080/00039890209601421.PubMedCrossRef Olivieri M, Poli A, Zuccaro P, Ferrari M, Lampronti G, de Marco R, Lo Cascio V, Pacifici R: Tobacco smoke exposure and serum cotinine in a random sample of adults living in Verona, Italy. Arch Environ Health. 2002, 57: 355-359. 10.1080/00039890209601421.PubMedCrossRef
Metadata
Title
GST-omega genes interact with environmental tobacco smoke on adult level of lung function
Authors
Kim de Jong
H Marike Boezen
Nick HT ten Hacken
Dirkje S Postma
Judith M Vonk
the LifeLines cohort study
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2013
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-14-83

Other articles of this Issue 1/2013

Respiratory Research 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.